Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

241

currently held

Exits tracked

163

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-10-07

BP Technology VenturesadminDirector Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change5 days ago

BP Technology Ventures5 days ago

Director Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change

admin

B.P. Marsh & PartnerscapitalCapital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change5 days ago

B.P. Marsh & Partners5 days ago

Capital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change

capital

Arkea CapitaladminBoard change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board6 days ago

Arkea Capital6 days ago

Board change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board

admin

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change6 days ago

Caledonia Investments6 days ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Cervinvest CapitaladminCEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed1 week ago

Cervinvest Capital1 week ago

CEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed

admin

Cervinvest CapitaladminChairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway1 week ago

Cervinvest Capital1 week ago

Chairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway

admin

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
ALIZÉ PHARMA II SAS Capital Santé 2	Pharma	France	Turenne Groupe	2014	2yr	Exited 2016	Jazz Pharmaceuticals	–
Duopharm IPDEV 1	Pharma	Senegal	Investisseurs et Partenaires	2010	6yr	Exited 2016	Founding pharmacists of Duopharm	–
PHARM’UP Naxicap Legacy Funds	Pharma	France	Naxicap Partners	2010	5yr	Exited 2015	–	–
Omega Pharma2 periods 21 Invest Italy IV	Pharma	Italy	21 Invest	2011	4yr	Active	–	–
Quotient Clinical2 periods GHO Capital Fund I LP	Pharma	UK	GHO Capital	2013	11yr	Active	–	–
AMCo Cinven Fifth Fund	Pharma	UK	Cinven	2012	3yr	Exited 2015	Concordia Healthcare Corp.	–
OctreoPharm VC Fonds Technologie Berlin	Pharma	Germany	IBB Ventures	2011	4yr	Exited 2015	Ipsen	–
Tianma Tianji Mandarin Capital Partners I	Pharma	China	Mindful Capital Partners	2010	5yr	Exited 2015	–	–
SINDER Cathay Capital Small Cap I	Pharma	China	Cathay Capital	2008	6yr	Exited 2014	–	–
ACTIVAERO BayBG Venture Capital	Pharma	Germany	BayBG Bayerische Beteiligungsgesellschaft	2005	9yr	Exited 2014	Vectura Group	–
Advencis Mérieux Innovation 1	Pharma	Europe	Merieux Equity Partners	2012	2yr	Exited 2014	bioMerieux	–
Celesio Haniel Family Equity	Pharma	Germany	Franz Haniel & Cie	1973	41yr	Exited 2014	McKesson	–
Egalet Sunstone Life Science Ventures III	Pharma	Denmark	Sunstone Life Science Ventures	2010	4yr	Exited 2014	–	–
Focus Pharmaceuticals Mobeus VCTs	Pharma	UK	Mobeus Equity Partners	2001	13yr	Exited 2014	Amdipharm Mercury	–
Nuvisan ADCURAM Group Holding	Pharma	Germany	ADCURAM Group	2010	4yr	Exited 2014	Family office and management	–
TREI IPEF IV Italy	Pharma	Italy	Synergo Capital SGR	2004	10yr	Exited 2014	aniMedica	–
OctoPlus FPCI Entreprise & Croissance I	Pharma	Netherlands	Generis Capital Partners	2011	2yr	Exited 2013	Dr Reddy's Laboratories	–
ZellBios AMB I	Pharma	Germany	Apheon	2007	6yr	Exited 2013	Deutsche Private Equity	–
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) Nordic Capital (early funds)	Pharma	United States	Nordic Capital	2005	7yr	Exited 2012	Sandoz (Novartis)	–
CAMED IPDEV 1	Pharma	France	Investisseurs et Partenaires	2003	8yr	Exited 2011	Local pharmacists and a French pharmaceutical wholesaler supplier	–
Nycomed Nordic Capital (early funds)	Pharma	Switzerland	Nordic Capital	2002	9yr	Exited 2011	Takeda	–
Nycomed Pharma Nordic Capital (early funds)	Pharma	Switzerland	Nordic Capital	2002	9yr	Exited 2011	Takeda	–
Saphar IPDEV 1	Pharma	Niger	Investisseurs et Partenaires	2006	5yr	Exited 2011	Djibrilla Hima, Mahamane Sekou and trusted co-investors	–
PHARMASTER (LABORATOIRES) Naxicap Legacy Funds	Pharma	France	Naxicap Partners	2003	7yr	Exited 2010	–	–
Bouty Healthcare Kairos Partners Private Equity Fund	Pharma	Italy	Consilium SGR	2003	6yr	Exited 2009	IBSA	–
Ipsen PAI LBO Fund	Pharma	France	PAI Partners	1998	8yr	Exited 2006	–	–
LifeCycle Pharma Nordic Biotech K/S	Pharma	Denmark	Nordic Biotech Advisors	2002	4yr	Exited 2006	–	–
Novosis SHS II	Pharma	Germany	SHS Gesellschaft für Beteiligungsmanagement	2001	5yr	Exited 2006	Acino	–
Medix EMZ Legacy	Pharma	France	EMZ Partners	2001	3yr	Exited 2004	–	–
Pharmion Corp. HealthCap (early funds)	Pharma	United States	HealthCap	2001	2yr	Exited 2003	–	–
Karo Pharma (Karo Bio) HealthCap (early funds)	Pharma	Sweden	HealthCap	1996	2yr	Exited 1998	–	–
Piex4 periods LBO France Mid Cap	Pharma	France	LBO France	2017	9yr	Active	–	–
Neftys Pharma3 periods For Talents Transmission	Pharma	France	For Talents Transmission	2022	4yr	Active	–	–
Recipharm3 periods CM-CIC Debt Fund 3	Pharma	Sweden	CIC Private Debt	2021	5yr	Active	–	–
ROTOP Pharmaka3 periods GENUI III	Pharma	Germany	GENUI	2024	2yr	Active	–	–
Avacare Health2 periods Amethis Fund II	Pharma	South Africa	Amethis	2021	5yr	Active	–	–
Biogaran2 periods Bpifrance	Pharma	France	Bpifrance Investissement	2025	1yr	Active	–	–
Gen Orph2 periods Crédit Mutuel Equity	Pharma	France	Crédit Mutuel Equity	2014	12yr	Active	–	–
Naogen Pharma2 periods Altur Investissement	Pharma	France	Altur Investissement	2018	8yr	Active	–	–
Ojer Pharma2 periods Easo Ventures II	Pharma	Spain	Easo Ventures	2014	12yr	Active	–	–
SGH Medical Pharma2 periods Mérieux Participations 2	Pharma	Belgium	Merieux Equity Partners	2018	8yr	Active	–	–
Simtra BioPharma Solutions2 periods Latin American Private Equity Fund VII	Pharma	USA	Advent International	–	–	Active	–	–
1Q Health NORD Holding Mid Cap	Pharma	Germany	NORD Holding	2024	2yr	Active	–	–
3P Biopharmaceuticals Eurazeo Private Debt V	Pharma	Spain	Eurazeo	2019	7yr	Active	–	–
4TEEN4 Pharmaceuticals GmbH Fruehphasen- und Wachstumsfonds Brandenburg	Pharma	Germany	Brandenburg Kapital	2019	7yr	Active	–	–
AB7 Grand Sud Ouest Capital	Pharma	France	Grand Sud-Ouest Capital	2010	16yr	Active	–	–
Abacus Pharmaceuticals Carlyle Sub-Saharan Africa Fund	Pharma	USA	The Carlyle Group	–	–	Active	–	–
Addvance Group capiton V	Pharma	Germany	capiton	2021	5yr	Active	–	–
AdipoPharma Cap Innov'Est 1	Pharma	France	Capital Grand Est	–	–	Active	–	–
Advanthera Columbus Life Sciences Fund IV	Pharma	Spain	Columbus Venture Partners	2024	2yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.